Jay Lichter
CIK 1376355 · President and CEO · last filed 2024-10-24
Jay Lichter is a President and CEO who has filed 46 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for JANX, was dated Nov 1, 2024. Across all open-market trades the lifetime net is −$531.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.0M across reported positions. 4 SEC filings were submitted jointly with Avalon BioVentures I, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.95M
4
46
-$531.27M
Filer Profile
11400 TOMAHAWK CREEK PARKWAY, SUITE 340
LEAWOOD, KS 66211
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JANX | Director | 582,095 | $17.10 | $9.95M | -$518.93M | 11 | 2024-10-24 |
| OTONOMY, INC. (OTIC) Delisted | Director | 0 | $0.08 | $0 | -$5.67M | 13 | 2022-06-23 |
| THOR | Director | 0 | $26.17 | $0 | $6.00M | 5 | 2020-01-24 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 2,345,543 | — | — | -$12.68M | 6 | 2015-07-17 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-01 | JANX | Notice (144) | −1,139 | -$60.7K | EDGAR |
| 2024-10-28 | JANX | Notice (144) | −3,419 | -$183.0K | EDGAR |
| 2024-10-24 | JANX | Notice (144) | −4,921 | -$262.7K | EDGAR |
| 2024-10-24 | JANX | Mixed | — | -$112.1K | EDGAR |
| 2024-10-21 | JANX | Notice (144) | −2,434 | -$120.5K | EDGAR |
| 2024-10-18 | JANX | Mixed | −6,643,376 | -$309.00M | EDGAR |
| 2024-10-17 | JANX | Notice (144) | −1,842 | -$92.2K | EDGAR |
| 2024-10-16 | JANX | Notice (144) | −10,957 | -$556.6K | EDGAR |
| 2024-09-30 | JANX | Notice (144) | −958 | -$44.3K | EDGAR |
| 2024-09-30 | JANX | Mixed | −1,220,432 | -$57.62M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.